Amalgamated Bank’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18K | Hold |
1,335
| – | – | ﹤0.01% | 2163 |
|
2025
Q1 | $15K | Buy |
1,335
+392
| +42% | +$4.4K | ﹤0.01% | 2192 |
|
2024
Q4 | $10K | Hold |
943
| – | – | ﹤0.01% | 2451 |
|
2024
Q3 | $12K | Hold |
943
| – | – | ﹤0.01% | 2379 |
|
2024
Q2 | $16K | Hold |
943
| – | – | ﹤0.01% | 2221 |
|
2024
Q1 | $14K | Sell |
943
-2,295
| -71% | -$34.1K | ﹤0.01% | 2301 |
|
2023
Q4 | $49K | Buy |
3,238
+466
| +17% | +$7.05K | ﹤0.01% | 2261 |
|
2023
Q3 | $39K | Hold |
2,772
| – | – | ﹤0.01% | 2360 |
|
2023
Q2 | $29K | Buy |
+2,772
| New | +$29K | ﹤0.01% | 2555 |
|
2022
Q2 | – | Sell |
-2,960
| Closed | -$26K | – | 3205 |
|
2022
Q1 | $26K | Buy |
+2,960
| New | +$26K | ﹤0.01% | 2725 |
|